PLRX - Pliant Therapeutics Inc
1.33
-0.060 -4.511%
Share volume: 289,680
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$1.39
-0.06
-0.04%
Summary score
34%
Profitability
35%
Dept financing
23%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.08%
Return on assets
-11.41%
Return on sales
-4340.93%
Return on invested capital
-107.63%
Total debt ratio
14.97%
Debt ratio change over timeo
-0.96%
Current Ratio
14.47%
Quick Ratio
15.64%
Cash Position Ratio
11.19%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-13.58%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
25.46%
Debt ratio change over timeo
0%
Current Ratio
11.96%
Quick Ratio
0%
Cash Position Ratio
3.57%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-10.22%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
27.58%
Debt ratio change over time
0%
Current Ratio
13.93%
Quick Ratio
0%
Cash Position Ratio
5.32%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104%
Return on assets
-103.46%
Return on sales
-1642.2%
Return on invested capital
-203.91%
Total debt ratio
-96.41%
Debt ratio change over time
-0.96%
Current Ratio
4.76%
Quick Ratio
5.37%
Cash Position Ratio
4.66%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PLRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -11.08% | 13.23% | 9.84% | 26.17% |
| Return on assets | -11.41% | 4.59% | 3.2% | 1.81% |
| Return on sales | -4340.93% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | -107.63% | 8.51% | 10.28% | 4.83% |
| Profitability | 0% | 83% | 73% | 67% |
| Total debt ratio | 14.97% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -0.96% | -16.59% | -73.52% | 21.11% |
| Dept financing | 4% | 22% | 16% | 50% |
| Current Ratio | 11.96% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 3.57% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 4% | 5% | 3% |
| Short-term ratios | PLRX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -13.58% | 5.82% | 4.08% | 0.78% |
| Return on sales | 0% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 13% |
| Total debt ratio | 25.46% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 20% | 15% | 25% |
| Current Ratio | 11.96% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 3.57% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 29% | 26% | 17% |